Enlivex Therapeutics Ltd. Annual Costs and Expenses in USD for 2021

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Enlivex Therapeutics Ltd. quarterly/annual Costs and Expenses history and growth rate for 2021.
  • Enlivex Therapeutics Ltd. Costs and Expenses for the quarter ending May 31, 2022 was $1M.
Costs and Expenses, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $126K Jan 1, 2021 Dec 31, 2021 20-F 2022-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.